Bristol Myers Squibb Co. (BMY)
66.91
-1.18
(-1.73%)
USD |
NYSE |
Sep 04, 11:04
Bristol Myers Squibb Cash and Short Term Investments (Annual) : 10.67B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 10.67B |
| December 31, 2024 | 10.86B |
| December 31, 2023 | 12.34B |
| December 31, 2022 | 9.401B |
| December 31, 2021 | 17.36B |
| December 31, 2020 | 16.54B |
| December 31, 2019 | 15.39B |
| December 31, 2018 | 8.884B |
| December 31, 2017 | 6.812B |
| December 31, 2016 | 6.35B |
| December 31, 2015 | 4.27B |
| December 31, 2014 | 7.435B |
| December 31, 2013 | 4.525B |
| December 31, 2012 | 2.829B |
| December 31, 2011 | 8.733B |
| December 31, 2010 | 7.301B |
| December 31, 2009 | 8.514B |
| December 31, 2008 | 8.265B |
| December 31, 2007 | 2.225B |
| December 31, 2006 | 4.013B |
| December 31, 2005 | 5.799B |
| December 31, 2004 | 7.474B |
| December 31, 2003 | 5.562B |
| Date | Value |
|---|---|
| December 31, 2002 | 3.989B |
| December 31, 2001 | 5.654B |
| December 31, 2000 | 3.385B |
| December 31, 1999 | 2.957B |
| December 31, 1998 | 2.529B |
| December 31, 1997 | 1.794B |
| December 31, 1996 | 2.185B |
| December 31, 1995 | 2.178B |
| December 31, 1994 | 2.423B |
| December 31, 1993 | 2.729B |
| December 31, 1992 | 2.385B |
| December 31, 1991 | 1.583B |
| December 31, 1990 | 1.958B |
| December 31, 1989 | 2.282B |
| December 31, 1988 | 1.710B |
| December 31, 1987 | 1.578B |
| December 31, 1986 | 1.192B |
| December 31, 1985 | 999.10M |
| December 31, 1984 | 759.40M |
| December 31, 1983 | 743.40M |
| December 31, 1982 | 611.60M |
| December 31, 1981 | 429.30M |
| December 31, 1980 | 367.60M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Johnson & Johnson | 20.10B |
| Eli Lilly & Co. | 7.268B |
| Merck & Co., Inc. | 14.69B |
| Pfizer Inc. | 13.60B |
| AstraZeneca PLC | 5.741B |